Who invested in AVEO?

AVEO has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for AVEO?

AVEO closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

AVEO

AVEO is a Massachusetts-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer.

Business Model:

Revenue: $94.3M

Employees: 51-200

Geographic Data

Address: 30 Winter Street

City: Boston

State: MA

Zip: 02108

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$55M

Raised Total:

$379M

Social

Facebook

Twitter

Crunchbase

Metrics

3,148,562Website Global Rank

5,190Website Monthly Traffic

Twitter Followers

Description

AVEO is a Massachusetts-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer.

Contact Phone:
+18574000101

Contact Email:

IPO Details

AVEO went public on 3/12/2010 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
3/12/2010

IPO Valuation:
$415M

Ticker Symbol:
AVEO

IPO Price:
$9/share

Amount Raised:
$81M

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
5/2010	Post-IPO Equity	1	$25M	Hercules Capital Hercules Capital
5/2005	Series C	5	$5M	Venrock Prospect Venture Partners MPM Bio IV NVS Strategic Fund Highland Capital Partners Applied Genomic Technology Capital Funds Venrock Prospect Venture Partners MPM Bio IV NVS Strategic Fund Highland Capital Partners Applied Genomic Technology Capital Funds
6/2011	Post-IPO Equity		$104.3M
5/2011	Post-IPO Equity		$7.5M
11/2010	Post-IPO Equity		$60.8M
1/2016	Post-IPO Equity	1	-	New Enterprise Associates New Enterprise Associates
5/2002	Series A	4	$15M	Venrock Prospect Venture Partners MPM Capital Greylock Venrock Prospect Venture Partners MPM Capital Greylock
10/2003	Series B	7	$42.7M	Venrock Prospect Venture Partners Oxford Bioscience Partners MPM Capital Highland Capital Partners Greylock Flagship Pioneering Venrock Prospect Venture Partners Oxford Bioscience Partners MPM Capital Highland Capital Partners Greylock Flagship Pioneering
8/2020	Post-IPO Debt	1	$35M	Hercules Capital Hercules Capital
3/2017	Post-IPO Equity		$15.5M
3/2021	Post-IPO Equity		$55.2M
6/2020	Post-IPO Equity		$51.1M
1/2013	Post-IPO Equity		$53.8M
5/2016	Post-IPO Equity	3	$17M	New Leaf Venture Partners Perceptive Advisors New Enterprise Associates New Enterprise Associates New Leaf Venture Partners Perceptive Advisors New Enterprise Associates New Enterprise Associates
5/2007	Series D	1	$53M	Venrock Venrock
7/2009	Venture Round	1	$20M	OSI Pharmaceuticals OSI Pharmaceuticals
8/2020	Post-IPO Debt		$45M	Hercules Capital, Inc.
6/2017	Post-IPO Debt		$14M	Hercules Capital, Inc
5/2011	Unattributed		$7.5M
6/2010	Post-IPO Equity		$25M	Hercules Technology Growth Capital, Inc.
1/2016	Post-IPO Equity	1	-	New Enterprise Associates New Enterprise Associates

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details